research and development

The company VIDIA was founded in 1991 by experienced research scientists. The research department was established as a self-contained department of the company in 1999. The main activities of the department are research, development and innovation of diagnostic kits. The development of new diagnostic kits is supported by the company financial resources or by government science foundations as grant projects. VIDIA’s scientists have a long time experience and technical background to develop, design and optimize the diagnostic kits based on ELISA or indirect immunofluorescence. They are skilled in sample handling and in in-vitro cell culturing, and capable of statistical evaluation of the results. The research department closely collaborates with scientific institutions such as the Academy of Sciences of the Czech Republic and with universities on government funded research projects. Currently, the company also focus on research in diagnostics for environmental pollutants and on new technologies for detection using nanoparticles.VIDIA participated or else participates in a variety of projects co-supported by Ministry of industry and trade of the Czech Republic or by Ministry of youth, education and sports of the Czech Republic – for details see below. During its existence the company has developed and marketed a set of diagnostic kits for detection of antibodies against herpetic viruses and assays for several biomarkers for research use.

The possibilities of cooperation:

The research department offers custom specified development and validation of kits (also IVD) or collaboration in research projects. Custom specified projects and proposals for cooperation with the research department sent to vidia@vidia.cz or to the address:

VIDIA Ltd., research department, Nad Safinou II/365, 252 42 Jesenice u Prahy

Our research scientists:

Department of virology and serology:

RNDr. Kateřina Roubalová CSc.

RNDr. Alena Forejtová, PhD.

Mgr. Marie Šteinbachová

MUDr. Pavel Jinoch

Mgr. Anna Bědajánková, PhD.

Environmental department:

Ing. Juraj Lábaj, PhD

Mgr. Heda Černohorská

Ing. Juraj Grígel 

Department of organic synthesis:

RNDr. Luděk Lepša, PhD.

RNDr. Zuzana Flegelová, CSc. 

Our publications:

Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis. Svarcová J, Fialová L, Bartos A, Steinbachová M, Malbohan I.Eur J Neurol. 2008 Nov;15(11):1173-9. Surface plasmon resonance biosensor for direct detection of antibody against Epstein-Barr virus.Vaisocherová H, Mrkvová K, Piliarik M, Jinoch P, Steinbachová M, Homola J.Biosens Bioelectron. 2007 Jan 15;22(6):1020-6. A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit. Pumannova M, Rezbova M, Svecova M, Hrbackova H, Novotna M, Ochotna J, Roubalova K.

Klinická Mikrobiologie a Infekční Lékařství. 2004,10(4):186-90.